1. |
NPAS2 |
ENSGALG00000016774 |
48 |
7 |
- |
- |
1.000 |
1.000 |
1.000 |
1.000 |
1.000 |
1.000 |
- |
1.000 |
neuronal PAS domain protein 2 [Source:NCBI gene;Acc:395433] |
2. |
K60 |
K60 |
4 |
1.701 |
- |
- |
- |
- |
0.881 |
0.820 |
- |
- |
- |
- |
|
3. |
MAPKAPK3 |
ENSGALG00000002283 |
30 |
1.524 |
- |
- |
- |
0.808 |
0.716 |
- |
- |
- |
- |
- |
Gallus gallus mitogen-activated protein kinase-activated protein kinase 3 (MAPKAPK3), mRNA. [Source:RefSeq mRNA;Acc:NM_001321558] |
4. |
ENSGALG00000026668 |
ENSGALG00000026668 |
34 |
1.479 |
- |
- |
- |
- |
0.750 |
- |
- |
0.729 |
- |
- |
|
5. |
FAM198B |
ENSGALG00000042411 |
65 |
0.965 |
- |
- |
- |
- |
- |
- |
- |
0.965 |
- |
- |
family with sequence similarity 198 member B [Source:HGNC Symbol;Acc:HGNC:25312] |
6. |
PDE9A |
ENSGALG00000016186 |
116 |
0.902 |
- |
- |
- |
- |
- |
- |
- |
0.902 |
- |
- |
phosphodiesterase 9A [Source:HGNC Symbol;Acc:HGNC:8795] |
7. |
LVRN |
ENSGALG00000002318 |
14 |
0.888 |
- |
- |
- |
- |
0.888 |
- |
- |
- |
- |
- |
laeverin [Source:HGNC Symbol;Acc:HGNC:26904] |
8. |
RNF151 |
ENSGALG00000034803 |
16 |
0.881 |
- |
- |
- |
- |
0.881 |
- |
- |
- |
- |
- |
ring finger protein 151, transcript variant X2 |
9. |
ABI1 |
ENSGALG00000007547 |
12 |
0.881 |
- |
- |
- |
- |
0.881 |
- |
- |
- |
- |
- |
abl interactor 1 [Source:NCBI gene;Acc:420489] |
10. |
BBS9 |
ENSGALG00000031650 |
13 |
0.881 |
- |
- |
- |
- |
0.881 |
- |
- |
- |
- |
- |
Bardet-Biedl syndrome 9, transcript variant X5 |
11. |
ENSGALG00000015321 |
ENSGALG00000015321 |
18 |
0.881 |
- |
- |
- |
- |
0.881 |
- |
- |
- |
- |
- |
|
12. |
FAM184B |
ENSGALG00000041854 |
43 |
0.881 |
- |
- |
- |
- |
0.881 |
- |
- |
- |
- |
- |
family with sequence similarity 184 member B [Source:HGNC Symbol;Acc:HGNC:29235] |
13. |
BRI3BP |
ENSGALG00000002913 |
3 |
0.881 |
- |
- |
- |
- |
0.881 |
- |
- |
- |
- |
- |
BRI3 binding protein [Source:NCBI gene;Acc:416812] |
14. |
FAM3D |
ENSGALG00000007152 |
4 |
0.881 |
- |
- |
- |
- |
0.881 |
- |
- |
- |
- |
- |
family with sequence similarity 3 member D [Source:HGNC Symbol;Acc:HGNC:18665] |
15. |
CD164 |
|
30 |
0.881 |
- |
- |
- |
- |
0.881 |
- |
- |
- |
- |
- |
CD164 molecule, transcript variant X2 |
16. |
FEM1A |
ENSGALG00000004168 |
14 |
0.881 |
- |
- |
- |
- |
0.881 |
- |
- |
- |
- |
- |
fem-1 homolog A [Source:HGNC Symbol;Acc:HGNC:16934] |
17. |
ENSGALG00000005427 |
ENSGALG00000005427 |
4 |
0.881 |
- |
- |
- |
- |
0.881 |
- |
- |
- |
- |
- |
|
18. |
Mar-02 |
Mar-02 |
7 |
0.881 |
- |
- |
- |
- |
0.881 |
- |
- |
- |
- |
- |
|
19. |
ARL8A_1 |
ENSGALG00000000606 |
23 |
0.881 |
- |
- |
- |
- |
0.881 |
- |
- |
- |
- |
- |
ADP ribosylation factor like GTPase 8A [Source:NCBI gene;Acc:421175] |
20. |
RFX7 |
ENSGALG00000041896 |
69 |
0.881 |
- |
- |
- |
- |
0.881 |
- |
- |
- |
- |
- |
regulatory factor X7 [Source:HGNC Symbol;Acc:HGNC:25777] |
21. |
UBE3D |
ENSGALG00000015860 |
6 |
0.881 |
- |
- |
- |
- |
0.881 |
- |
- |
- |
- |
- |
ubiquitin protein ligase E3D [Source:HGNC Symbol;Acc:HGNC:21381] |
22. |
ENSGALG00000026583 |
ENSGALG00000026583 |
1 |
0.881 |
- |
- |
- |
- |
0.881 |
- |
- |
- |
- |
- |
|
23. |
ENSGALG00000012324 |
ENSGALG00000012324 |
4 |
0.881 |
- |
- |
- |
- |
0.881 |
- |
- |
- |
- |
- |
|
24. |
LOC396098 |
ENSGALG00000015461 |
3 |
0.881 |
- |
- |
- |
- |
0.881 |
- |
- |
- |
- |
- |
B6.1 |
25. |
F13A1 |
ENSGALG00000012802 |
16 |
0.881 |
- |
- |
- |
- |
0.881 |
- |
- |
- |
- |
- |
coagulation factor XIII A chain [Source:NCBI gene;Acc:395420] |
26. |
KIAA0825 |
ENSGALG00000014664 |
25 |
0.879 |
- |
- |
- |
- |
- |
- |
- |
0.879 |
- |
- |
KIAA0825, transcript variant X7 |
27. |
SUFU |
ENSGALG00000008096 |
307 |
0.877 |
- |
- |
- |
- |
- |
- |
- |
0.877 |
- |
- |
SUFU negative regulator of hedgehog signaling [Source:NCBI gene;Acc:374118] |
28. |
ARSA |
ENSGALG00000035824 |
299 |
0.867 |
- |
- |
- |
0.867 |
- |
- |
- |
- |
- |
- |
arylsulfatase A [Source:HGNC Symbol;Acc:HGNC:713] |
29. |
DALRD3 |
ENSGALG00000036976 |
46 |
0.86 |
- |
- |
- |
- |
- |
- |
0.860 |
- |
- |
- |
DALR anticodon binding domain containing 3 [Source:HGNC Symbol;Acc:HGNC:25536] |
30. |
SPINK7 |
SPINK7 |
254 |
0.834 |
- |
- |
- |
- |
- |
0.834 |
- |
- |
- |
- |
|
31. |
CPGC |
CPGC |
33 |
0.831 |
- |
- |
- |
- |
- |
- |
- |
0.831 |
- |
- |
|
32. |
LOC426743 |
ENSGALG00000001242 |
248 |
0.826 |
- |
- |
- |
0.826 |
- |
- |
- |
- |
- |
- |
probable beta-D-xylosidase 5-like |
33. |
NMUR1 |
ENSGALG00000007714 |
32 |
0.822 |
- |
- |
- |
- |
- |
- |
0.822 |
- |
- |
- |
Gallus gallus neuromedin U receptor 1 (NMUR1), mRNA. [Source:RefSeq mRNA;Acc:NM_001318436] |
34. |
MYO7A |
ENSGALG00000031450 |
16 |
0.82 |
- |
- |
- |
- |
- |
0.820 |
- |
- |
- |
- |
myosin VIIA [Source:HGNC Symbol;Acc:HGNC:7606] |
35. |
ZBTB37 |
ENSGALG00000004597 |
1 |
0.82 |
- |
- |
- |
- |
- |
0.820 |
- |
- |
- |
- |
zinc finger and BTB domain containing 37 [Source:HGNC Symbol;Acc:HGNC:28365] |
36. |
TNNI3K |
ENSGALG00000011353 |
10 |
0.82 |
- |
- |
- |
- |
- |
0.820 |
- |
- |
- |
- |
TNNI3 interacting kinase [Source:NCBI gene;Acc:100533999] |
37. |
ENSGALG00000012217 |
ENSGALG00000012217 |
8 |
0.82 |
- |
- |
- |
- |
- |
0.820 |
- |
- |
- |
- |
|
38. |
ENSGALG00000001754 |
ENSGALG00000001754 |
45 |
0.82 |
- |
- |
- |
- |
- |
0.820 |
- |
- |
- |
- |
|
39. |
HBE1 |
ENSGALG00000028273 |
189 |
0.82 |
- |
- |
- |
- |
- |
0.820 |
- |
- |
- |
- |
hemoglobin subunit epsilon 1 [Source:NCBI gene;Acc:428114] |
40. |
ENSGALG00000009329 |
ENSGALG00000009329 |
2 |
0.82 |
- |
- |
- |
- |
- |
0.820 |
- |
- |
- |
- |
|
41. |
DLK1 |
ENSGALG00000011244 |
5 |
0.82 |
- |
- |
- |
- |
- |
0.820 |
- |
- |
- |
- |
delta like non-canonical Notch ligand 1 [Source:NCBI gene;Acc:423459] |
42. |
FADS1L1 |
ENSGALG00000020485 |
3 |
0.82 |
- |
- |
- |
- |
- |
0.820 |
- |
- |
- |
- |
fatty acid desaturase 1-like 1 |
43. |
CDCP2 |
ENSGALG00000010752 |
4 |
0.82 |
- |
- |
- |
- |
- |
0.820 |
- |
- |
- |
- |
CUB domain containing protein 2 [Source:HGNC Symbol;Acc:HGNC:27297] |
44. |
ITIH3 |
ENSGALG00000001697 |
2 |
0.82 |
- |
- |
- |
- |
- |
0.820 |
- |
- |
- |
- |
inter-alpha-trypsin inhibitor heavy chain 3 [Source:HGNC Symbol;Acc:HGNC:6168] |
45. |
PRPS2 |
ENSGALG00000016592 |
165 |
0.82 |
- |
- |
- |
- |
- |
0.820 |
- |
- |
- |
- |
phosphoribosyl pyrophosphate synthetase 2 [Source:NCBI gene;Acc:418639] |
46. |
ARL15 |
ENSGALG00000014911 |
13 |
0.82 |
- |
- |
- |
- |
- |
0.820 |
- |
- |
- |
- |
ADP ribosylation factor like GTPase 15 [Source:HGNC Symbol;Acc:HGNC:25945] |
47. |
gga-mir-1634-2 |
gga-mir-1634-2 |
1 |
0.82 |
- |
- |
- |
- |
- |
0.820 |
- |
- |
- |
- |
|
48. |
ABCA7 |
ENSGALG00000002453 |
22 |
0.82 |
- |
- |
- |
- |
- |
0.820 |
- |
- |
- |
- |
ATP-binding cassette, sub-family A (ABC1), member 7, transcript variant X5 |
49. |
ENSGALG00000003796 |
ENSGALG00000003796 |
7 |
0.82 |
- |
- |
- |
- |
- |
0.820 |
- |
- |
- |
- |
|
50. |
SBSPON |
ENSGALG00000043532 |
5 |
0.82 |
- |
- |
- |
- |
- |
0.820 |
- |
- |
- |
- |
somatomedin B and thrombospondin type 1 domain containing [Source:HGNC Symbol;Acc:HGNC:30362] |
51. |
ENSGALG00000008069 |
ENSGALG00000008069 |
2 |
0.82 |
- |
- |
- |
- |
- |
0.820 |
- |
- |
- |
- |
|
52. |
ENSGALG00000029065 |
ENSGALG00000029065 |
2 |
0.82 |
- |
- |
- |
- |
- |
0.820 |
- |
- |
- |
- |
|
53. |
SFT2D2 |
ENSGALG00000019228 |
10 |
0.82 |
- |
- |
- |
- |
- |
0.820 |
- |
- |
- |
- |
SFT2 domain containing 2 [Source:HGNC Symbol;Acc:HGNC:25140] |
54. |
DUSP8 |
ENSGALG00000006647 |
3 |
0.82 |
- |
- |
- |
- |
- |
0.820 |
- |
- |
- |
- |
dual specificity phosphatase 8 [Source:HGNC Symbol;Acc:HGNC:3074] |
55. |
NPHS2 |
ENSGALG00000004163 |
850 |
0.82 |
- |
- |
- |
- |
- |
0.820 |
- |
- |
- |
- |
NPHS2, podocin [Source:HGNC Symbol;Acc:HGNC:13394] |
56. |
LMTK2 |
ENSGALG00000003479 |
46 |
0.82 |
- |
- |
- |
- |
- |
0.820 |
- |
- |
- |
- |
lemur tyrosine kinase 2 [Source:HGNC Symbol;Acc:HGNC:17880] |
57. |
KRT12 |
ENSGALG00000019715 |
1 |
0.82 |
- |
- |
- |
- |
- |
0.820 |
- |
- |
- |
- |
keratin 12 [Source:HGNC Symbol;Acc:HGNC:6414] |
58. |
SLITRK6 |
ENSGALG00000016904 |
30 |
0.82 |
- |
- |
- |
- |
- |
0.820 |
- |
- |
- |
- |
SLIT and NTRK like family member 6 [Source:HGNC Symbol;Acc:HGNC:23503] |
59. |
ENSGALG00000010336 |
ENSGALG00000010336 |
16 |
0.82 |
- |
- |
- |
- |
- |
0.820 |
- |
- |
- |
- |
|
60. |
NOD1 |
ENSGALG00000036807 |
10 |
0.82 |
- |
- |
- |
- |
- |
0.820 |
- |
- |
- |
- |
Gallus gallus nucleotide binding oligomerization domain containing 1 (NOD1), mRNA. [Source:RefSeq mRNA;Acc:NM_001318438] |
61. |
FOXE3 |
|
11 |
0.82 |
- |
- |
- |
- |
- |
0.820 |
- |
- |
- |
- |
forkhead box E3 |
62. |
TSHR |
ENSGALG00000010572 |
1 |
0.82 |
- |
- |
- |
- |
- |
0.820 |
- |
- |
- |
- |
thyroid stimulating hormone receptor [Source:NCBI gene;Acc:428900] |
63. |
H2B-I |
H2B-I |
13 |
0.82 |
- |
- |
- |
- |
- |
0.820 |
- |
- |
- |
- |
|
64. |
C4orf45 |
ENSGALG00000045983 |
1 |
0.82 |
- |
- |
- |
- |
- |
0.820 |
- |
- |
- |
- |
chromosome 4 open reading frame 45 [Source:HGNC Symbol;Acc:HGNC:26342] |
65. |
FAM124B |
ENSGALG00000005118 |
2 |
0.82 |
- |
- |
- |
- |
- |
0.820 |
- |
- |
- |
- |
family with sequence similarity 124 member B [Source:HGNC Symbol;Acc:HGNC:26224] |
66. |
FABP2 |
ENSGALG00000011986 |
15 |
0.82 |
- |
- |
- |
- |
- |
0.820 |
- |
- |
- |
- |
fatty acid binding protein 2 [Source:NCBI gene;Acc:422678] |
67. |
PODN |
ENSGALG00000021869 |
71 |
0.82 |
- |
- |
- |
- |
- |
0.820 |
- |
- |
- |
- |
podocan [Source:HGNC Symbol;Acc:HGNC:23174] |
68. |
ARL6 |
ENSGALG00000019215 |
11 |
0.82 |
- |
- |
- |
- |
- |
0.820 |
- |
- |
- |
- |
ADP ribosylation factor like GTPase 6 [Source:NCBI gene;Acc:418433] |
69. |
ENSGALG00000026079 |
ENSGALG00000026079 |
4 |
0.82 |
- |
- |
- |
- |
- |
0.820 |
- |
- |
- |
- |
|
70. |
ATP6V1C2 |
ENSGALG00000016446 |
3 |
0.82 |
- |
- |
- |
- |
- |
0.820 |
- |
- |
- |
- |
ATPase H+ transporting V1 subunit C2 [Source:HGNC Symbol;Acc:HGNC:18264] |
71. |
TINAG |
ENSGALG00000016300 |
5 |
0.82 |
- |
- |
- |
- |
- |
0.820 |
- |
- |
- |
- |
tubulointerstitial nephritis antigen [Source:NCBI gene;Acc:421888] |
72. |
SOX6 |
ENSGALG00000006074 |
102 |
0.82 |
- |
- |
- |
- |
- |
0.820 |
- |
- |
- |
- |
Gallus gallus SRY-box 6 (SOX6), mRNA. [Source:RefSeq mRNA;Acc:NM_001318451] |
73. |
GHRHR-LR |
ENSGALG00000005242 |
2 |
0.82 |
- |
- |
- |
- |
- |
0.820 |
- |
- |
- |
- |
growth-hormone releasing hormone-like peptide receptor |
74. |
KCNV2 |
ENSGALG00000010173 |
2 |
0.82 |
- |
- |
- |
- |
- |
0.820 |
- |
- |
- |
- |
potassium voltage-gated channel modifier subfamily V member 2 [Source:HGNC Symbol;Acc:HGNC:19698] |
75. |
ENSGALG00000005960 |
ENSGALG00000005960 |
3 |
0.818 |
- |
- |
- |
0.818 |
- |
- |
- |
- |
- |
- |
|
76. |
CLCN6 |
ENSGALG00000004590 |
3 |
0.818 |
- |
- |
- |
0.818 |
- |
- |
- |
- |
- |
- |
chloride voltage-gated channel 6 [Source:NCBI gene;Acc:419488] |
77. |
PSMD4 |
ENSGALG00000028505 |
16 |
0.818 |
- |
- |
- |
0.818 |
- |
- |
- |
- |
- |
- |
proteasome 26S subunit, non-ATPase 4 [Source:NCBI gene;Acc:100216364] |
78. |
ZNF330 |
ENSGALG00000009868 |
257 |
0.818 |
- |
- |
- |
0.818 |
- |
- |
- |
- |
- |
- |
zinc finger protein 330 [Source:NCBI gene;Acc:422453] |
79. |
EPHA2 |
ENSGALG00000039895 |
12 |
0.818 |
- |
- |
- |
0.818 |
- |
- |
- |
- |
- |
- |
EPH receptor A2 [Source:HGNC Symbol;Acc:HGNC:3386] |
80. |
ASPA |
ENSGALG00000004669 |
10 |
0.818 |
- |
- |
- |
0.818 |
- |
- |
- |
- |
- |
- |
aspartoacylase [Source:HGNC Symbol;Acc:HGNC:756] |
81. |
ZFYVE21 |
ENSGALG00000011534 |
7 |
0.818 |
- |
- |
- |
0.818 |
- |
- |
- |
- |
- |
- |
zinc finger FYVE-type containing 21 [Source:NCBI gene;Acc:423486] |
82. |
ESR1 |
ENSGALG00000012973 |
3 |
0.818 |
- |
- |
- |
0.818 |
- |
- |
- |
- |
- |
- |
estrogen receptor 1 [Source:NCBI gene;Acc:396099] |
83. |
SNORA44 |
SNORA44 |
29 |
0.817 |
- |
- |
- |
0.817 |
- |
- |
- |
- |
- |
- |
|
84. |
RPE65 |
ENSGALG00000011259 |
51 |
0.816 |
- |
- |
- |
- |
- |
0.816 |
- |
- |
- |
- |
RPE65, retinoid isomerohydrolase [Source:NCBI gene;Acc:395700] |
85. |
SLC27A6 |
ENSGALG00000000184 |
98 |
0.813 |
- |
- |
- |
- |
- |
0.813 |
- |
- |
- |
- |
solute carrier family 27 member 6 [Source:HGNC Symbol;Acc:HGNC:11000] |
86. |
PTPRO |
ENSGALG00000013085 |
26 |
0.807 |
- |
- |
- |
0.807 |
- |
- |
- |
- |
- |
- |
protein tyrosine phosphatase, receptor type O [Source:NCBI gene;Acc:373911] |
87. |
TRPV1 |
ENSGALG00000004649 |
17 |
0.802 |
- |
- |
- |
- |
0.802 |
- |
- |
- |
- |
- |
transient receptor potential cation channel subfamily V member 1 [Source:NCBI gene;Acc:395259] |
88. |
DNASE2 |
DNASE2 |
58 |
0.801 |
- |
- |
- |
- |
- |
- |
- |
0.801 |
- |
- |
|
89. |
TVB |
TVB |
11 |
0.799 |
- |
- |
- |
- |
- |
0.799 |
- |
- |
- |
- |
|
90. |
C1QL1 |
ENSGALG00000028031 |
788 |
0.798 |
- |
- |
- |
- |
- |
- |
0.798 |
- |
- |
- |
complement C1q like 1 [Source:HGNC Symbol;Acc:HGNC:24182] |
91. |
ENSGALG00000014539 |
ENSGALG00000014539 |
31 |
0.797 |
- |
- |
- |
- |
- |
0.797 |
- |
- |
- |
- |
|
92. |
NPTXR |
ENSGALG00000041604 |
256 |
0.796 |
- |
- |
- |
- |
- |
- |
- |
0.796 |
- |
- |
neuronal pentraxin receptor [Source:HGNC Symbol;Acc:HGNC:7954] |
93. |
MPL |
ENSGALG00000009965 |
334 |
0.795 |
- |
- |
- |
- |
- |
0.795 |
- |
- |
- |
- |
MPL proto-oncogene, thrombopoietin receptor [Source:NCBI gene;Acc:414804] |
94. |
LRRK1 |
LRRK1 |
35 |
0.792 |
- |
- |
- |
- |
- |
0.792 |
- |
- |
- |
- |
|
95. |
RALGPS1_1 |
ENSGALG00000000906 |
7 |
0.788 |
- |
- |
- |
0.788 |
- |
- |
- |
- |
- |
- |
Ral GEF with PH domain and SH3 binding motif 1 [Source:HGNC Symbol;Acc:HGNC:16851] |
96. |
ENSGALG00000015743 |
ENSGALG00000015743 |
22 |
0.784 |
- |
- |
- |
- |
0.784 |
- |
- |
- |
- |
- |
|
97. |
ARHGAP8 |
ENSGALG00000019261 |
281 |
0.779 |
- |
- |
- |
- |
- |
- |
0.779 |
- |
- |
- |
Rho GTPase activating protein 8 [Source:NCBI gene;Acc:418239] |
98. |
ENSGALG00000012250 |
ENSGALG00000012250 |
581 |
0.778 |
- |
- |
- |
0.778 |
- |
- |
- |
- |
- |
- |
|
99. |
VTG1 |
ENSGALG00000039354 |
17 |
0.777 |
- |
- |
- |
0.777 |
- |
- |
- |
- |
- |
- |
vitellogenin 1 [Source:NCBI gene;Acc:424547] |
100. |
IRX5 |
ENSGALG00000003588 |
79 |
0.777 |
- |
- |
- |
- |
- |
- |
- |
0.777 |
- |
- |
iroquois homeobox 5 [Source:HGNC Symbol;Acc:HGNC:14361] |